Draft Report on Carcinogens (RoC) Monograph on Selected Viruses

Document, Report, or Other Product Information
TitleDraft Report on Carcinogens (RoC) Monograph on Selected Viruses
SubjectThe draft RoC monograph on selected viruses (Epstein-Barr virus, human immunodeficiency virus type 1, human T-cell lymphotrophic virus type 1, Kaposi sarcoma-associated herpes virus, and Merkel cell polyoma virus) consists of two parts: (1) a cancer evaluation component, which is a literature based assessment of the potential carcinogenicity of selected viruses and (2) a substance profile which contains the NTP preliminary listing recommendation for selected viruses in the RoC, the science considered key in reaching that recommendation, and information on use, production, human exposure and Federal regulations or guidelines to limit exposure to selected viruses.
Purpose (e.g., abstract)The RoC is a Congressionally mandated, biennial document that identifies and discusses agents, substances, mixtures, or exposure circumstances (collectively referred to as “substances”) that may pose a hazard to human health by virtue of their carcinogenicity. Substances are listed in the RoC following a four-part process (http://ntp.niehs.nih.gov/go/rocprocess) and using established criteria (http://ntp.niehs.nih.gov/go/15209). As per the NTP’s process for preparing the RoC, each draft RoC monograph is peer reviewed by a panel of experts in a public forum.
Information Product Contact
ISI or HISAhisa
ICNIEHS
IC Division, Office, or ProgramDivision of the National Toxicology Program
NIH ContactMary Wolfe
919-541-7539
wolfe@niehs.nih.gov
Reviewer Names and Expertise
Review DescriptionDraft RoC Monograph on Selected Viruses: Peer-review Meeting
Date of Review2015-12-17
Number of Reviewers7-9
Reviewer Nominations Requested?no
Upcoming Panels, Eventshttp://ntp.niehs.nih.gov/go/38854
Technical/Draft Reports, Public Comments and Presentationshttp://ntp.niehs.nih.gov/go/733995
Past Roster, Notices, Meeting Updateshttp://ntp.niehs.nih.gov/go/38854
Reviewer ExpertiseEpidemiology, toxicology, genetic toxicology, molecular epidemiology, molecular toxicology, carcinogenicity
How SelectedNTP
Opportunity for Public Comment?yes
Agenda Date2015-06-16